- Home
- MHLD vs ASRT Comparison
MHLD vs ASRT Comparison
Compare MHLD & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHLD
- ASRT
- Stock Information
- Founded
- MHLD 2007
- ASRT 1995
- Country
- MHLD Bermuda
- ASRT United States
- Employees
- MHLD N/A
- ASRT N/A
- Industry
- MHLD Property-Casualty Insurers
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- MHLD Finance
- ASRT Health Care
- Exchange
- MHLD Nasdaq
- ASRT Nasdaq
- Market Cap
- MHLD 96.4M
- ASRT 78.3M
- IPO Year
- MHLD 2008
- ASRT 1997
- Fundamental
- Price
- MHLD $0.59
- ASRT $0.67
- Analyst Decision
- MHLD
- ASRT Strong Buy
- Analyst Count
- MHLD 0
- ASRT 3
- Target Price
- MHLD N/A
- ASRT $3.08
- AVG Volume (30 Days)
- MHLD 165.4K
- ASRT 419.7K
- Earning Date
- MHLD 03-10-2025
- ASRT 03-12-2025
- Dividend Yield
- MHLD N/A
- ASRT N/A
- EPS Growth
- MHLD N/A
- ASRT N/A
- EPS
- MHLD N/A
- ASRT N/A
- Revenue
- MHLD $56,436,000.00
- ASRT $124,961,000.00
- Revenue This Year
- MHLD N/A
- ASRT $0.96
- Revenue Next Year
- MHLD N/A
- ASRT $12.72
- P/E Ratio
- MHLD N/A
- ASRT N/A
- Revenue Growth
- MHLD N/A
- ASRT N/A
- 52 Week Low
- MHLD $0.57
- ASRT $0.67
- 52 Week High
- MHLD $2.27
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- MHLD 33.88
- ASRT 33.74
- Support Level
- MHLD $0.67
- ASRT $0.70
- Resistance Level
- MHLD $0.75
- ASRT $0.75
- Average True Range (ATR)
- MHLD 0.06
- ASRT 0.05
- MACD
- MHLD -0.01
- ASRT -0.00
- Stochastic Oscillator
- MHLD 0.00
- ASRT 3.02
About MHLD Maiden Holdings Ltd.
Maiden Holdings Ltd provides reinsurance products and services to regional and specialty property and casualty insurers. The company operates in two segments: AmTrust Reinsurance and Diversified Reinsurance. The AmTrust Reinsurance segment provides products that cover workers' compensation, commercial package, commercial auto, and extended warranty. The Diversified Reinsurance segment provides small and midsize regional and specialty insurers with reinsurance capital products. Its revenues also include fee income earned from both its GLS business and IIS business as well as income generated from its investment portfolio.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.